Monique Howard-Davis
Primary Care · Beachwood, OHNPI 1093004483
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 53 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 10.8% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,556 and has fallen 56.4% since, to $678 in 2025. Among primary care clinicians in OH with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 53 payments — averaging $97.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Puma Biotechnology, Inc.$556
- Otsuka America Pharmaceutical, Inc.$479
- Inspire Medical Systems, Inc.$362
- E.r. Squibb & Sons, L.L.C.$355
- AstraZeneca$351
- Johnson & Johnson$349
- plus $3K from 21 others
What the payments were for
- Food & beverage$5,142100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Puma Biotechnology, Inc. | 6 | $556 |
| Otsuka America Pharmaceutical, Inc. | 4 | $479 |
| Inspire Medical Systems, Inc. | 4 | $362 |
| E.r. Squibb & Sons, L.L.C. | 3 | $355 |
| AstraZeneca(2 entities) | 3 | $351 |
| Johnson & Johnson | 3 | $349 |
| AbbVie | 4 | $338 |
| Jazz Pharmaceuticals Inc. | 2 | $254 |
| Biogen | 2 | $200 |
| Alkermes, Inc. | 2 | $190 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 2 | $181 |
| Xeris Pharmaceuticals, Inc. | 1 | $125 |
| Regeneron Healthcare Solutions, Inc. | 1 | $125 |
| Supernus Pharmaceuticals, Inc. | 1 | $125 |
| Idorsia Pharmaceuticals US Inc | 1 | $125 |
| GSK | 2 | $119 |
| Eisai Inc. | 1 | $112 |
| Novo Nordisk | 2 | $110 |
| Sage Therapeutics, LLC | 1 | $109 |
| Sanofi | 1 | $101 |
| Pfizer | 1 | $100 |
| Gilead | 1 | $93 |
| Sanofi-aventis U.S. LLC | 1 | $90 |
| Coloplast | 1 | $80 |
| Neurelis, Inc. | 1 | $64 |
| Alnylam Pharmaceuticals Inc. | 1 | $36 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$414
- ABILIFY MAINTENA$375
- COBENFY$355
- Epidiolex$254
- ABILIFY ASIMTUFII$250
- INVEGA SUSTENNA$229
- LINZESS$125
- Nerlynx$125
- QELBREE$125
- GVOKE HYPOPEN$125
- QUVIVIQ$125
- INVEGA TRINZA$119
- VRAYLAR$117
- LENVIMA$112
- Inspire$105
- REXULTI$105
- FABRAZYME$101
- FASENRA$101
- SPINRAZA$100
How this compares
$5,142 in reported general payments places this provider in the 90th percentile of 321 primary care providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Duloxetine Hcl | 19 | $386 |
| Buspirone Hcl | 14 | $329 |
| Sertraline Hcl | 11 | $190 |
| Benztropine Mesylate | 13 | $117 |
| Quetiapine Fumarate | 13 | $111 |
| Fluoxetine Hcl | 13 | $76 |
| Escitalopram Oxalate | 11 | $53 |
| Trazodone Hcl | 11 | $44 |
Paid to pharmacies, not to this prescriber.
Other primary care in Beachwood
- Jessica St ClairBeachwood$3K
- Adine EdwardsSpringfield$14K
- Kelly McKenna TaulbeeHamilton$12K
- Lindsay ChappellFairlawn$11K
- Laura HolligerNorth Canton$10K
- Caitlyn FrantzDayton$10K
- Brandy RichardsCleveland$8K
- Regan HeagenFindlay$8K
- Zachary HaleBeavercreek$7K
- Katherine ElliotWesterville$7K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.